Prot #BP40283: Phase 2, Randomized, Double-Blind, Placebo Controlled Study to Assess the Effects of RO6889450 in Patients with Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Project: Research project

Project Details

StatusActive
Effective start/end date3/12/193/12/22

Funding

  • PPD Investigator Services, LLC (Prot #BP40283)
  • Genentech, Inc. (Prot #BP40283)